Sign in
A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD
Vrinda S. Hershberger, MD, PhD
On Demand Cases, Courses, and Papers
2021
Reduced Incidence of Post-Injection Endophthalmitis With Pre-filled Syringes
Daniel B. Roth, MD
2020
Current Practice Preferences and Antisepsis Protocols for Intravitreal Anti-vascular Endothelial Growth Factor Injections
David Xu, MD
2019
Category: Instrumentation and Devices